Metraipolis › archive › dc_d21443fdd655

Synergistic MDM2-STAT3 Inhibition Demonstrates Strong Anti-Leukemic Efficacy in Acute Lymphoblastic Leukemia — Europe PMC PMID:40943567

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40943567
DOI
10.3390/ijms26178648
License (as archived)
solo-consultazione
Archived
2026-11-10T03:07:12.931Z
SHA-256 of the archived text
17f2dd0fbd7c9944f0d872121b42980608b1f2e7fd2bb2aeb3980a731f2a3309
Stable URL of this page
https://metraipolis.com/documento/dc_d21443fdd655

How to cite

Synergistic MDM2-STAT3 Inhibition Demonstrates Strong Anti-Leukemic Efficacy in Acute Lymphoblastic Leukemia — Europe PMC PMID:40943567 — Europe PMC (en), https://europepmc.org/article/MED/40943567 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d21443fdd655 (Metraipolis archive dc_d21443fdd655, sha256 17f2dd0fbd7c9944f0d872121b42980608b1f2e7fd2bb2aeb3980a731f2a3309)
BibTeX
@misc{dcd21443fdd655,
  title = {Synergistic MDM2-STAT3 Inhibition Demonstrates Strong Anti-Leukemic Efficacy in Acute Lymphoblastic Leukemia — Europe PMC PMID:40943567},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40943567},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d21443fdd655; sha256 17f2dd0fbd7c9944f0d872121b42980608b1f2e7fd2bb2aeb3980a731f2a3309},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40943567. Agents can read the archived copy with the MCP tool read_document.